Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

TMPRSS2 inhibitor found to be a novel and effective therapeutic option against pan-variant SARS-CoV-2 infections

TMPRSS2 inhibitor found to be a novel and effective therapeutic option against pan-variant SARS-CoV-2 infections

1 Apr 2022
Study investigates rapid nanopore whole-genome sequencing approach for identifying genetic variants

Study investigates rapid nanopore whole-genome sequencing approach for identifying genetic variants

1 Apr 2022
As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

1 Apr 2022
COVID-19 incinerators set new record for merseyside manufacturer

COVID-19 incinerators set new record for merseyside manufacturer

From Inciner8 Limited 1 Apr 2022
Managing hazardous waste during the Covid-19 pandemic

Managing hazardous waste during the Covid-19 pandemic

From Inciner8 Limited 1 Apr 2022
No evidence of SARS-CoV-2 in the U.K.'s wild deer population

No evidence of SARS-CoV-2 in the U.K.'s wild deer population

31 Mar 2022
NIH program provides a real-time risk assessment of variants of SARS-CoV-2

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

31 Mar 2022
The longest duration of SARS-CoV-2 positivity after initial diagnosis

The longest duration of SARS-CoV-2 positivity after initial diagnosis

31 Mar 2022
The mucosal antibody response to SARS-CoV-2

The mucosal antibody response to SARS-CoV-2

31 Mar 2022
How effective are household cleaning agents against SARS-CoV-2?

How effective are household cleaning agents against SARS-CoV-2?

31 Mar 2022
The evolution of the SARS-CoV-2 spike protein

The evolution of the SARS-CoV-2 spike protein

31 Mar 2022
Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

31 Mar 2022
UIC researchers projected to receive $22 million to study long COVID-19

UIC researchers projected to receive $22 million to study long COVID-19

31 Mar 2022
Novaplex real-time PCR assays can reliably, rapidly detect SARS-CoV-2 in patient samples

Novaplex real-time PCR assays can reliably, rapidly detect SARS-CoV-2 in patient samples

31 Mar 2022
Additional boosters recommended for certain individuals at higher risk of severe COVID-19 outcomes

Additional boosters recommended for certain individuals at higher risk of severe COVID-19 outcomes

31 Mar 2022
KHN’s ‘What the Health?’: Funding for the next pandemic

KHN’s ‘What the Health?’: Funding for the next pandemic

31 Mar 2022
NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

31 Mar 2022
Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

31 Mar 2022
Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

31 Mar 2022
Study identifies implications of long-COVID on long term physical and mental health

Study identifies implications of long-COVID on long term physical and mental health

31 Mar 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback